Literature DB >> 17318769

Significant increase in the prevalence of non-rheumatic aortic valve disease in patients with type 2 diabetes mellitus.

M-R Movahed1, M Hashemzadeh, M M Jamal.   

Abstract

BACKGROUND: Diabetes mellitus (DM) is a major risk for coronary artery disease and hyperlipidemia. The role of Diabetes as an independent risk factor for aortic stenosis or regurgitation has been controversial. The goal of this study was to evaluate any association between DM and non-rheumatic aortic valve disease using a very large database.
METHOD: We used PTF documents containing discharge diagnosis using ICD-9 codes of inpatient treatment from all Veterans Health Administration Hospitals (VA). The data were stratified using ICD-9 code for DM (n=293,124), a control group with hypertension (HTN) but no DM (n=552,623). The occurrence of non-rheumatic aortic valve disease in DM patients was studied in comparison with the control. We performed multivariate analysis adjusting for coronary artery disease (CAD), congestive heart failure (CHF) , smoking, renal failure, and hyperlipidemia.
RESULTS: Non-rheumatic aortic valve disease diagnosis was present in 7,322 (2.5%) of DM patients vs. 10,906 (2.0%) in the control group. (25% relative increase) Using multivariate analysis, DM remained strongly associated with non-rheumatic aortic valve disease: (odds ratio (OR): 2.23, 95%; confidential interval (CI): 2.16 to 2.30 p<0. 0001).
CONCLUSION: Type II diabetes mellitus is independently associated with non-rheumatic aortic valve disease. Since women were underrepresented in our study, our results apply only to diabetic men. The cause of this association is not known. CONDENSE ABSTRACT:The role of Diabetes as an independent risk factor for aortic stenosis or regurgitation has been controversial. We used PTF documents containing discharge diagnosis using ICD-9 codes of inpatient treatment from Veterans Health Administration Hospitals (VA) were analysed.( DM (n=293,124), a control group with hypertension (HTN) but no DM (n=552,623)). The occurrence of non-rheumatic aortic valve disease in DM patients was studied in comparison with the control. Non-rheumatic aortic valve disease diagnosis was present in 7,322 (2.5%) of DM patients vs. 10,906 (2.0%) in the control group. Using multivariate analysis, DM remained strongly associated with non-rheumatic aortic valve disease: (odds ratio (OR): 2.23, 95%; confidential interval (CI): 2.16 to 2.30 p<0. 0001). Since women were underrepresented in our study, our results apply only to diabetic men.

Entities:  

Mesh:

Year:  2007        PMID: 17318769     DOI: 10.1055/s-2007-949656

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  5 in total

Review 1.  Echocardiographic feature of diabetic cardiomyopathy: where are we now?

Authors:  Kazuaki Negishi
Journal:  Cardiovasc Diagn Ther       Date:  2018-02

2.  Infective endocarditis with left to right intracardiac fistula due to Streptococcus anginosus - a rare complication caused by an even rarer bacterium.

Authors:  Robert Forster; Fernando Peixoto Ferraz de Campos; Silvana Maria Lovisolo; Vera Demarchi Aiello; João Augusto Dos Santos Martines
Journal:  Autops Case Rep       Date:  2013-12-31

3.  Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification.

Authors:  Magdalena Kopytek; Piotr Mazur; Michał Ząbczyk; Anetta Undas; Joanna Natorska
Journal:  Diabetologia       Date:  2021-09-07       Impact factor: 10.122

Review 4.  Heart failure in sub-Saharan Africa: a literature review with emphasis on individuals with diabetes.

Authors:  Andre Pascal Kengne; Anastase Dzudie; Eugene Sobngwi
Journal:  Vasc Health Risk Manag       Date:  2008

5.  Additive effect of aortic regurgitation degree on left ventricular strain in patients with type 2 diabetes mellitus evaluated via cardiac magnetic resonance tissue tracking.

Authors:  Li-Ting Shen; Li Jiang; Ya-Wen Zhu; Meng-Ting Shen; Shan Huang; Rui Shi; Yuan Li; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2022-03-11       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.